| 29 Health - Hepatitis Resources |
| CDC Confirms Las Vegas Hepatitis Outbreak Stemmed From Needle Reuse
|
| The CDC has confirmed that a Las Vegas hepatitis C outbreak was caused by clinic workers improperly reusing syringes and medicine vials.
|
| Open |
Open Tab |
May 19, 2008 |
Provides Information |
| Clinic That May Have Infected 40,000 With HIV, Hepatitis Closed
|
| The city of Las Vegas has shut down a clinic where up to 40,000 people may have been exposed to hepatitis C and the HIV virus through the reuse of syringes and vials.
|
| Open |
Open Tab |
March 3, 2008 |
Provides Information |
| D |
| Diabetes Doubles Liver Cancer Risk For Patients With Advanced Hepatitis C
|
| Patients who have chronic hepatitis C with advanced fibrosis have twice the risk of developing liver cancer if they also have diabetes.
|
| Open |
Open Tab |
June 2, 2008 |
Provides Information |
| Discovery Of New Antiviral Mechanism Promising For Hepatitis C Treatment
|
| A team of researchers led by biologists at the University of California, San Diego has discovered a completely new mechanism that mammalian cells employ to fight infections of the Hepatitis C virus, which affects approximately 2.7 million Americans and 170 million people worldwide.
|
| Open |
Open Tab |
October 22, 2007 |
Provides Information |
| Dramatic Rise Found In Hepatitis C-related Deaths In The United States
|
| Hepatitis C-related deaths in the United States increased by 123 percent from 1995 through 2004, the most recent year for which data are available. Mortality rates peaked in 2002, then declined slightly overall, while continuing to rise among people 55 to 64 years old.
|
| Open |
Open Tab |
March 25, 2008 |
Provides Information |
| Drug effective for hepatitis C patients with low platelets
|
| For patients with hepatitis C, having a low blood platelet count is a frequent complication associated with advanced disease.
|
| Open |
Open Tab |
January 2, 2008 |
Provides Information |
| E |
| Effective Treatment Found For Hepatitis C Patients With Low Blood-platelet Counts
|
| For patients with hepatitis C, having a low blood platelet count is a frequent complication associated with advanced disease. This problem is compounded by the fact that standard antiviral treatment for the disease can further reduce platelet numbers to dangerously low levels, effectively denying these patients the treatment they urgently need.
|
| Open |
Open Tab |
January 5, 2008 |
Provides Information |
| F |
| Farfield Scientific Awarded Contract to Develop Diagnostic Test for Hepatitis A, B and C
|
| The project, code named SABIO, deploys one of the latest and most sensitive optical sensor technologies based on hollow or ‘slot’ waveguides to detect multiple analytes in sera, making it possible to test for these diseases in a single, label free, point of care assay.
|
| Open |
Open Tab |
November 23, 2007 |
Provides Information |
| G |
| Grapefruit Compound Inhibits Hepatitis C Virus
|
| The grapefruit flavonoid naringenin inhibits the secretion of Hepatitis C virus (HCV) in infected cells and could offer a new approach for treating the disease, according to a Harvard Medical School study.
|
| Open |
Open Tab |
May 6, 2008 |
Provides Information |
| Greater need for education regarding blood borne viruses
|
| A new cohort study could facilitate targeted interventions for adolescent offenders who are at a high risk of hepatitis C (HCV) infection and obesity related liver disease.
|
| Open |
Open Tab |
December 10, 2007 |
Provides Information |
| H |
| Hepatitis B Vaccine Not Associated With Childhood Multiple Sclerosis
|
| Vaccinating against the hepatitis B virus does not appear to be associated with the risk of developing multiple sclerosis in childhood, according to a new article.
|
| Open |
Open Tab |
December 4, 2007 |
Provides Information |
| Hepatitis B Virus Triggers Cell 'Suicide' In Patients With Chronic Infection
|
| Scientists from UCL (University College London) have identified a key difference between people who can fight the Hepatitis B virus (HBV) off successfully and those who fail to do so -- that a group of cells important in controlling the disease are triggered to 'commit suicide' in patients who are chronically infected. This discovery provides an important new focus for developing therapies or vaccines that boost the body's ability to manage this infection.
|
| Open |
Open Tab |
April 9, 2008 |
Provides Information |
| Hepatitis C warning for US clinic
|
| As many as 40,000 people who used a Las Vegas clinic are being urged to be tested for HIV and the blood-borne hepatitis C virus, US officials say.
|
| Open |
Open Tab |
February 28, 2008 |
Provides Information |
| Hepatitis C: Identification Of A Protein That Inhibits The Virus
|
| Scientists in the Laboratoire Hépatite C of the Institut de Biologie de Lille in collaboration with INSERM Unit 602 and a laboratory at Stanford University have provided evidence of a protein, called EWI-2wint, that inhibits the hepatitis C virus at an early stage of its infective cycle. This research suggests possible new perspectives for the development of therapies to block the virus before it enters a cell.
|
| Open |
Open Tab |
April 17, 2008 |
Provides Information |
| Hepatitis C: Less Treatment OK for Some
|
| Study Shows Successful Outcomes for Patients Who Quit Drug Therapy Early.
|
| Open |
Open Tab |
January 3, 2008 |
Provides Information |
| How Hep C bypasses cell defences
|
| The potentially-fatal hepatitis C virus evades the body's natural defences by slipping directly from cell to cell, scientists have found.
|
| Open |
Open Tab |
November 2, 2007 |
Provides Information |
| How To Fight Treacherous Hepatitis B
|
| One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
|
| Open |
Open Tab |
October 1, 2007 |
Provides Information |
| L |
| Liver Cancer Marker Could Yield Blood Test For Early Detection
|
| In the face of an emerging liver cancer crisis in Asia, researchers at the Chinese University of Hong Kong have developed a test that could help millions.
|
| Open |
Open Tab |
September 20, 2007 |
Provides Information |
| M |
| Majority of Europeans with hepatitis C remain undiagnosed
|
| A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.
|
| Open |
Open Tab |
October 1, 2007 |
Provides Information |
| N |
| New theory suggests how hepatitis C may cause rare immune disease
|
| Of the hepatitis alphabet, the C variant may be the nastiest. In 1990, researchers observed that most patients with hepatitis C also develop a rare autoimmune disease called mixed cryoglobulinemia, a condition that frequently leads to cancer, arthritis or both.
|
| Open |
Open Tab |
May 10, 2008 |
Provides Information |
| New Theory Suggests How Hepatitis C May Cause Rare Immune Disease
|
| Of the hepatitis alphabet, the C variant may be the nastiest. In 1990, researchers observed that most patients with hepatitis C also develop a rare autoimmune disease called mixed cryoglobulinemia, a condition that frequently leads to cancer, arthritis or both.
|
| Open |
Open Tab |
May 13, 2008 |
Provides Information |
| O |
| Oglufanide disodium in new hepatitis C trial
|
| Physicians at Southern Health have started a phase IIa clinical trial designed to test the efficacy of a new strategy for defeating hepatitis C viral infection, one of the toughest infectious diseases in the modern world.
|
| Open |
Open Tab |
August 26, 2007 |
Provides Information |
| Optimal therapy for U.S. hepatitis C patients
|
| As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day.
|
| Open |
Open Tab |
December 30, 2007 |
Provides Information |
| P |
| Pill Boosts Platelets In Hepatitis C Patients
|
| It's not a cure, but this may be some of the best news patients infected with the hepatitis C virus (HCV) have heard in a long time: A new drug, eltrombopag, appears to be effective in boosting low platelet counts, one of the major reasons why patients can't endure antiviral treatments.
|
| Open |
Open Tab |
November 29, 2007 |
Provides Information |
| Positive Findings In Treating Patients With Advanced Hepatitis C
|
| The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large.
|
| Open |
Open Tab |
April 25, 2008 |
Provides Information |
| S |
| Safer, More Efficient Medication For Hepatitis B Treatment Found
|
| Patients with hepatitis B who did not respond to lamivudine therapy had a better virological response after switching to entecavir for a year.
|
| Open |
Open Tab |
June 28, 2008 |
Provides Information |
| Statin Drug Used To Lower Cholesterol Effective For Hepatitis C Treatment
|
| The drug, Fluvastatin, has been approved since 1993 by the U.S. Food and Drug Administration for the treatment of elevated cholesterol in adults. Millions of patients have taken Fluvastatin for cholesterol without difficulty.
|
| Open |
Open Tab |
May 15, 2008 |
Provides Information |
| W |
| Warning about lack of attention given to hepatitis
|
| A report by the World Hepatitis Alliance has called for an increased focus on hepatitis and says the disease should be given the same attention as AIDS, tuberculosis and malaria.
|
| Open |
Open Tab |
May 20, 2008 |
Provides Information |